Tracey Ziomek's Company Details
Newark, CA, US • 50 - 99 Employees
BioTech/Drugs
InCarda Therapeutics is an early-stage drug delivery company pioneering a novel approach of treating cardiovascular diseases and conditions by the inhalation route. The lead product under development is an inhaled therapy to treat a common atrial arrhythmia, paroxysmal atrial fibrillation (PAF).
Cardiovascular
Inhalation therapy
Biotechnology
Pharmaceuticals
Clinical Development
Drug Formulation
Commercialization
Clinical Research
Pre-Clinical Research
Regulatory Affairs
B2B
BioTech/Drugs
Commercial Physical Research